APH
77
2
AMAT
54
-3
R
67
-3
CLX
48
3
NI
80
5
AON
62
4
CFG
64
2
SO
75
7
MET
64
-2
INTC
15
-3
CAH
69
2
ISRG
71
-2
STT
67
-4
CL
56
2
SYK
48
2
WEC
70
5
URI
59
-4
PEG
64
4
DUK
59
5
IR
52
-8
APH
77
2
AMAT
54
-3
R
67
-3
CLX
48
3
NI
80
5
AON
62
4
CFG
64
2
SO
75
7
MET
64
-2
INTC
15
-3
CAH
69
2
ISRG
71
-2
STT
67
-4
CL
56
2
SYK
48
2
WEC
70
5
URI
59
-4
PEG
64
4
DUK
59
5
IR
52
-8
Financhill
Back

Alphatec Holdings 10K Form

Sell
47

ATEC
Alphatec Holdings

Last Price:
$12.41
Seasonality Move:
0.99%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive ATEC News And Ratings

See the #1 stock for the next 7 days that we like better than ATEC

ATEC Financial Statistics

Sales & Book Value

Annual Sales: $611.6M
Cash Flow: $-16.7M
Price / Cash Flow: 0
Annual Sales: $-0.59
Price / Book: 56.64

Profitability

EPS (TTM): -1.15000
Net Income (TTM): $-165.5M
Gross Margin: $424.3M
Return on Equity: -691.37%
Return on Assets: -21.5%

Alphatec Holdings Earnings Forecast

Key Alphatec Holdings Financial Ratios

  • The Gross Profit Margin over the past 24 years for ATEC is 69.37%.
  • The Selling, General & Administrative Expenses for ATEC have been equal to 73.61% of Gross Profit Margin.
  • The Research & Development expenses have been 13.20% of Revenue.
  • The Net Earning history of ATEC is -26.51% of Total Revenues.
  • Per Share Earnings over the last 24 years have been positive in 13 years.

Alphatec Holdings Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Health Care Equipment & Supplies
Sector: Health Care
Current Symbol: ATEC
CUSIP: 02081G
Website: atecspine.com

Debt

Debt-to-Equity Ratio: -6.38
Current Ratio: 2.75
Quick Ratio: 1.54

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 108.4

ATEC Technical Analysis vs Fundamental Analysis

Sell
47
Alphatec Holdings (ATEC) is a Sell

Is Alphatec Holdings a Buy or a Sell?

  • Alphatec Holdings stock is rated a Sell
    The current Alphatec Holdings [ATEC] share price is $12.43. The Score for ATEC is 47, which is 6% below its historic median score of 50, and infers higher risk than normal.